Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Varenna

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Reumatismo|August 7, 2002
[Pain assessment in clinical Rheumatology]L. Sinigaglia, M. Varenna
Reumatismo|April 17, 2009
[Adherence to treatment of osteoporosis: an open question]M Varenna, L Sinigaglia
Reumatismo|November 6, 2010
[The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis]M Varenna, D Gatti
Reumatismo|July 30, 2014
A clinical overview of bone marrow edemaM Manara, M Varenna
Reumatismo|December 17, 2009
[Observational studies in osteoporosis treatment]S Giannini, M Varenna
Journal of Endocrinological Investigation|May 14, 2008
Bone involvement in exogenous hypercortisolismL Sinigaglia, D Mazzocchi, M Varenna
Clinical and Experimental Rheumatology|May 18, 2005
Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathyE G Favalli, M Varenna, L Sinigaglia
Clinical and Experimental Rheumatology|July 1, 1996
Reflex sympathetic dystrophy syndrome following acute gouty arthritisF Zucchi, M Varenna, L Binelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 26, 2001
Unbalanced diet to lower serum cholesterol level is a risk factor for postmenopausal osteoporosis and distal forearm fractureM Varenna, L Binelli, F Zucchi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 1, 2022
Reply to: appropriate dosing of burosumab in tumor-induced osteomalaciaC Crotti, F Zucchi, C Alfieri, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Reumatismo|August 7, 2002
[Pain assessment in clinical Rheumatology]L. Sinigaglia, M. Varenna
Reumatismo|April 17, 2009
[Adherence to treatment of osteoporosis: an open question]M Varenna, L Sinigaglia
Reumatismo|November 6, 2010
[The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis]M Varenna, D Gatti
Reumatismo|July 30, 2014
A clinical overview of bone marrow edemaM Manara, M Varenna
Reumatismo|December 17, 2009
[Observational studies in osteoporosis treatment]S Giannini, M Varenna
Journal of Endocrinological Investigation|May 14, 2008
Bone involvement in exogenous hypercortisolismL Sinigaglia, D Mazzocchi, M Varenna
Clinical and Experimental Rheumatology|May 18, 2005
Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathyE G Favalli, M Varenna, L Sinigaglia
Clinical and Experimental Rheumatology|July 1, 1996
Reflex sympathetic dystrophy syndrome following acute gouty arthritisF Zucchi, M Varenna, L Binelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 26, 2001
Unbalanced diet to lower serum cholesterol level is a risk factor for postmenopausal osteoporosis and distal forearm fractureM Varenna, L Binelli, F Zucchi, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 1, 2022
Reply to: appropriate dosing of burosumab in tumor-induced osteomalaciaC Crotti, F Zucchi, C Alfieri, et al.
Pageof 5